Tahoe Therapeutics is a biotechnology company revolutionizing drug discovery by focusing on the biology of actual patients. Their innovative Mosaic platform enables scalable in vivo data generation with single-cell resolution, allowing for the mapping of drug effects on patient-derived cells across diverse biological contexts. They are in the process of creating the world’s largest in vivo single-cell perturbation atlas. By utilizing advanced machine learning and compiling biologically relevant datasets, Tahoe aims to enhance the speed and efficacy of drug discovery, leading to better treatments for patients in need.